Actively Recruiting
Linking Brain Network Dynamics to Imminent Smoking Lapse Risk and Behavior
Led by Penn State University · Updated on 2026-05-05
150
Participants Needed
1
Research Sites
225 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Most attempts to quit smoking end in relapse, or a return to regular smoking. One of the biggest threats to cessation is a lapse (i.e., any cigarette use during a quit attempt). Thus, characterizing why lapses occur is essential to understanding and preventing smoking relapse. Functional magnetic resonance imaging (fMRI) is a promising method for characterizing the psychological processes that lead to smoking lapses because it provides a way to measures patterns of brain activity thought to reflect relevant mental processes as they change over time. However, methodological issues have hindered the ability to capitalize on this potential and prevented an understanding of how brain activity and corresponding psychological processes unfold in the critical moments that immediately precede a smoking lapse. The proposed project will address this knowledge gap using a novel fMRI paradigm adapted from a well-validated behavioral lapse task. The goals of the project are to characterize changes in brain activity that lead up to a lapse and to investigate how these changes are related to concurrent affect and subsequent cigarette use.
CONDITIONS
Official Title
Linking Brain Network Dynamics to Imminent Smoking Lapse Risk and Behavior
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be between the ages of 21 and 65.
- Participants must be fluent English speakers.
- Participants must pass an MRI safety screening.
- Participants must report smoking at least six cigarettes per day continuously for at least the 12 preceding months.
- Participants must have a baseline expired-air carbon monoxide exceeding 10 parts per million in order to verify smoking status.
You will not qualify if you...
- Not willing to refrain from using nicotine for 12 hours before the experimental lab visit.
- Known risk from exposure to high-field strength magnetic fields such as having pacemakers.
- Presence of any irremovable metallic foreign objects in the body, such as braces.
- Questionable history of metallic fragments likely to create artifact on MRI scans.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Pennsylvania State University
University Park, Pennsylvania, United States, 16870
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here